Cargando…
FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma
Mesenchymal transition (MES transition) is a hallmark of glioblastoma multiforme (GBM), however, the mechanism regulating the process remains to be elucidated. Here we report that FoxM1 drives ADAM17/EGFR activation loop to promote MES transition in GBM. Firstly, FoxM1 expression was positively asso...
Autores principales: | Zhang, Chunli, Han, Xiu, Xu, Xiao, Zhou, Zhengrong, Chen, Xi, Tang, Yu, Cheng, Jie, Moazzam, Nida Fatima, Liu, Fei, Xu, Jing, Peng, Wanxin, Du, Fengyi, Zhang, Bin, Song, Zhiwen, Zeng, Jian, Gong, Aihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920065/ https://www.ncbi.nlm.nih.gov/pubmed/29700308 http://dx.doi.org/10.1038/s41419-018-0482-4 |
Ejemplares similares
-
Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer
por: Xu, Menglin, et al.
Publicado: (2020) -
ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
por: Jiao, Xiaodong, et al.
Publicado: (2018) -
PRMT5 promotes epithelial‐mesenchymal transition via EGFR‐β‐catenin axis in pancreatic cancer cells
por: Ge, Lu, et al.
Publicado: (2019) -
FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020) -
Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)